Categories: DNANews

Pioneering Scientist David Deamer to receive ABRF Award for Outstanding Contributions to Biomolecular Technologies

 LEXINGTON, Ky. , Nov. 2, 2024 /PRNewswire/ — The Association of Biomolecular Resource Facilities (ABRF) is pleased to announce the selection of David Deamer, Ph.D., Research Professor of Biomolecular Engineering at the University of California, Santa Cruz as the next recipient of the ABRF Award, which recognizes Outstanding Contributions to Biomolecular Technologies.

Over his scientific career, Deamer has focused on biological and synthetic membranes. In 1989, Deamer proposed that it may be possible to sequence a DNA molecule by passing it through a nanoscopic pore embedded in a lipid bilayer membrane. Deamer, Daniel Branton, (Harvard University), and John Kasianowitz (NIST) demonstrated the feasibility of this concept in 1996. Collaborative work with Mark Akeson at UC Santa Cruz reported proof of principle in 1999 by showing that a nanopore could distinguish between sequences of adenine and cytosine in RNA molecules. Oxford Nanopore Technology, founded in the UK in 2005, has developed and distributed multiple devices that incorporate nanopore sequencing concepts. Deamer was elected to the National Academy of Inventors in 2023. In the same year, Deamer, Branton, and Akeson were recipients of the Golden Goose Award at a ceremony in Washington DC. This award recognizes research that attracted much skepticism at first but later resulted in significant societal impact.

ABRF Past President and Award Committee Chair Rich Cole, with the New York State Department of Health’s Wadsworth Center, described Deamer’s impact:

“Core facilities are the backbone of modern research, providing access to cutting-edge technologies and expertise. They accelerate scientific discovery by fostering collaboration, enhancing reproducibility, and maximizing the efficient use of resources. Deamer uses two core facilities to support his research, both related to nanopore sequencing of DNA. One of these is a nanopore sequencing center established by Professor Karen Miga, a member of the Biomolecular Engineering faculty at the University of California, Santa Cruz. The center features a PromethION instrument capable of sequencing a human genome in five hours. The other core facility he uses is the Wasatch Biolab (WBL) in Heber, Utah. WBL also uses a PromethION to provide nanopore sequencing services to the research community.

The ABRF Award, the association’s highest scientific honor, has been presented to an extraordinary group of researchers and innovators since 1994, including several Nobel Prize recipients.

Dr. Deamer will accept the Award at the ABRF 2025 Annual Meeting, March 23-26, in Las Vegas.

For more information on ABRF, visit www.abrf.org.

Provided by Newswise, online resource for knowledge-based news at www.newswise.com

Media Contacts: Ken Schoppmann
Executive Director
ken.schoppmann@abrf.org
Phone: 8595149835

Contact: ABRF@ABRF.org

View original content:https://www.prnewswire.com/news-releases/pioneering-scientist-david-deamer-to-receive-abrf-award-for-outstanding-contributions-to-biomolecular-technologies-302294110.html

SOURCE Association of Biomolecular Resource Facilities (ABRF)

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

21 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

21 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

2 days ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

2 days ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

2 days ago